Common Femoral Artery Stenting: Computed Tomography Angiography Based Long-Term Patency

Rabellino Martin1, Di Caro Vanesa G1, Juan Valle Raleigh1

  • 1Department of Angiography and Endovascular Therapy, 37533Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Insights

Self-expandable nitinol stents show high long-term patency for common femoral artery (CFA) disease, offering a viable alternative to surgery. This study confirms excellent technical success and low complication rates for CFA stent placement.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Common femoral endarterectomy is the standard treatment for atherosclerotic common femoral artery (CFA) disease.
  • This procedure has significant associated morbid-mortality rates.
  • Endovascular options are being explored as alternatives.

Purpose of the Study:

  • To evaluate the long-term patency of common femoral artery (CFA) lesions treated with stent placement.
  • To identify risk factors associated with restenosis after CFA stenting.
  • To compare outcomes of endovascular stenting with traditional surgical approaches.

Main Methods:

  • A retrospective observational study of patients undergoing endovascular stent placement for CFA lesions.
  • Clinical follow-up and multi-detector computed tomography angiography (MD-CTA) were used to assess in-stent restenosis (ISR) and patency rates.
  • Analysis included primary, assisted, and secondary patency, as well as freedom from target lesion revascularization.

Main Results:

  • 100% technical success was achieved in 35 extremities treated with nitinol stents.
  • Mean follow-up was 32.2 months, with high estimated primary (79.5%) and secondary (96.3%) patency rates at 60 months.
  • In-stent restenosis (ISR) rates were 55.6% for <20%, 33.3% for 20-70%, and 11.1% for ≥70%.

Conclusions:

  • Endovascular stenting with self-expandable nitinol stents in CFA lesions offers high technical success and low complication rates.
  • While mild intimal hyperplasia was noted, long-term patency remains high.
  • CFA stent placement is a suitable alternative therapeutic option for selected patients with common femoral artery disease.
Abstract